You are here:Home-Webinars-Inhaled antimicrobials: Do we get the drug to the bug?

Inhaled antimicrobials: Do we get the drug to the bug?


Speaker: Harm A. W. M. Tiddens, Professor of Pediatric Pulmonology and Allergology, Erasmus Medical Center Sophia Children’s Hospital (Netherlands)

Moderator: Harpal Singh Dhillon, Global Medical Value Director & Founder, AntiBx (UK)

In this webinar, Harm Tiddens discussed the relation between structural and functional abnormalities of the lung and how this can impact upon the deposition pattern and efficacy of inhaled antibiotics. He also presented the learnings of his research group’s computational fluid dynamic modelling studies and explained why the expectation that inhaled antibiotics result in high concentrations in the lung is, unfortunately, a misconception.

The presentation was followed by a Q&A session.


This live webinar and interactive Q&A session was broadcast on 28 April 2020.

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us by email: revive@gardp.org.

Download Harm’s responses to open audience questions here
2020-06-22T13:18:13+00:00